openPR Logo
Press release

Vascular Disrupting Agents Market Lucrative Technological breakthroughs 2025

Vascular Disrupting Agents Market Lucrative Technological

The process of formation of new blood vessels is called angiogenesis. Angiogenesis is essential for growth and multiplication of solid tumors. If size of the tumor is less than 2 mm3, growth factors and nutrients are supplied by diffusion.

However, if the tumor size is larger, blood supply to the tumor needs to be established. Dependence of tumor cells on newly formed blood vessels for their growth and metastasis has resulted in focusing on ‘angiogenesis’ as a novel target for cancer treatment.

Vascular disrupting agents is a new and promising class of targeted anticancer agents having antiangiogenic effect. These agents primarily act by disrupting the formed abnormal solid tumor vasculature by targeting the immature dysmorphic endothelial cells.

They exert their anticancer effect by targeting new tumor blood vessels that are formed by angiogenesis, blocking the supply of blood to the formed tumor. This makes the tumor deprived of essential nutrients and oxygen, leading to tumor cell death.

Obtain Report Details:
https://www.transparencymarketresearch.com/vascular-disrupting-agents-market.html

Vascular disrupting agents are primarily used in the treatment of different types of cancer such as ovarian cancer, thyroid cancer, liver cancer, colorectal cancer, glioblastoma, and renal cell carcinoma.

Vascular disrupting agents are of two types: small-molecule and ligand-directed vascular disrupting agents. Small-molecule vascular disrupting agents have been further classified into tubulin-binding agents and flavonoids. Tubulin binding agents act by selectively binding to the β-tubulin colchicine binding site, which weakens microtubules and leads to change in the 3-dimensional shape of endothelial cells.

Endothelial cells interrupt the tumor blood vessel, thereby leading to necrosis of cancer cells within the tumor. Examples of tubulin-binding agents include combretastatin, crolibulin, verubulin, and fosbretabulin. The other type of small-molecule vascular disrupting agents are flavonoids, which promote localized release of the tumor necrosis factor TNFα from nearby activated macrophage cells.

Examples of flavonoids include 5, 6-dimethylxanthenone-4-acetic acid (DMXAA) and icaritin/pexastimogene devacirepvec. Ligand-directed vascular disrupting agents primarily act by delivering toxic effects to tumor endothelium. The small-molecule vascular disrupting agents segment is expected to expand significantly during the forecast period, as a majority of molecules in the pipeline are small molecules.

Additionally, high incidence and prevalence rate of cancer, increase in the demand for newer treatment options, and the large number of ongoing clinical trials boost the vascular disrupting agents market. However, unsatisfactory results of clinical trials and low availability of safety data restrain the vascular disrupting agents market.

In terms of geography, the global vascular disrupting agents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads the global market, followed by Europe.

Growth of the market in North America is attributable to high incidence and prevalence rate of cancer, rise in the geriatric population, and increase in the demand for advance treatment options in the region. Asia Pacific is an emerging market for vascular disrupting agents, due to developing health care infrastructure, increasing patient awareness, and rising government expenditure on health care in the region.

Make Enquiry @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32492

However, low awareness among patients, high cost of therapy, and lack of availability of treatment options are factors restraining the vascular disrupting agents market in regions such as Middle East & Africa and Latin America.

Major players operating in the global vascular disrupting agents market include Mateon Therapeutics, Immune Pharmaceuticals, Nereus Pharmaceuticals, Madrigal Pharmaceuticals, Inc., Celgene Corporation, Bionomics Ltd., and Lees Pharmaceutical Holdings.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact TMR

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website:http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vascular Disrupting Agents Market Lucrative Technological breakthroughs 2025 here

News-ID: 861746 • Views: 117

More Releases from Transparency Market Research

Fuel Dispenser Market - Global Industry Analysis, Size, Share, Growth, Trends, a …
Albany, NY - Fuel Dispenser Market: Introduction In terms of value, the global fuel dispenser market is expected to reach ~US$ 2 Bn by 2030, expanding at a CAGR of ~4% during the forecast period. Based on volume, the global fuel dispenser market is estimated to reach 662,058 units by 2030, expanding at a CAGR of ~4% during the forecast period. In terms of type, the submersible system segment holds leading
Brazil Flavored and Functional Water Market Outlook, Gains Traction, Analysis An …
According to the report, the market will exhibit an impressive CAGR of 7.3% during the projection period. With this rate of growth, by the end of 2024, the market will be valued around US$9.4 bn. It is a considerable growth from the initial valuation recorded at US$5 bn in 2015. A new report by Transparency Market Research expects the Brazil flavored functional water market to grow at considerable pace over
Advantame Market Trends , Incredible Growth Opportunities, Volume, Value Growth …
Increasing health issues among the population led to an increase in the demand for non-caloric sweetener. In the global food and beverage market, the demand for advantame is on rising owing to its non-caloric sweetener properties. Advantame is one of the most recent, high potency low-calorie sweeteners to arrive in the food and beverage market with clean sugar-like the taste. The rising consumption of unhealthy/ comfort sugary food with high calories
Trends in the Feed ingredients - Outlook, Share and Opportunities in Grooming Re …
Escalating demand for high nutritional value meat is one of the major factor driving the growth of global feed ingredients market. In the global meat products market, safety is one of the major concern among meat manufacturers owing to stringent rules laid by government organizations during the handling, procurement, processing, storage, and distribution of animal products. The inclusion of high nutritive value feed ingredient into animal feed results in more

All 5 Releases


More Releases for Vascular

Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorder
Stromal Vascular Fraction Market
Prevalence of knee osteoarthritis is expected to provide a significant opportunity to the new class cell therapies to penetrate the market. Moreover, soaring demand for reconstructive breast therapies are also estimated to fuel the market in near future. Among all the clinical trials being conducted for stromal vascular fraction therapeutics, breast reconstruction procedures have reported highest proportion and outcomes for it to appear promising, as per the research conducted by
Global Large Bore Vascular Closure Devices Market 2018 - Abbott Vascular, St. Ju …
Apex Market Reports, recently published a detailed market research study focused on the “Large Bore Vascular Closure Devices Market” across the global, regional and country level. The report provides 360° analysis of “Large Bore Vascular Closure Devices Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the
Vascular Stent Market Dreadfully High over 2025
Global Vascular Stent Market: Overview As the incidence of peripheral artery disease grows, the global demand for vascular stents is expected to swell as well. Vascular stents are medical devices that are usually placed as part of peripheral artery angioplasty. In simple terms, a stent is a plastic or metal tube that is inserted into an anatomic vessel so as to keep the passageway from closing. Iliac, carotid, and femoral
Vascular Grafts Market - Global Industry Analysis 2025
Vascular Grafts are medical devices used to bypass the infected or diseased blood vessels. Vascular grafts are required to replace injured blood vessels, veins, and arteries and to substitute hard blood vessels or valves. Blood flow is redirected from one place to another by introducing a graft with the help of surgical reconstruction process. These grafts can be synthetic, semi-synthetic or taken from the patient’s body. Request to download and view
Vascular Access Devices Market Outlook
Global Vascular Access Devices Market: Snapshot The demand in the global market for vascular access devices, which are medical devices made of hollow and flexible tubes of latex or silicone that enable an access to the bloodstream, has been consistently incrementing owing to growing number of surgeries performed each year across the world. Vascular access devices are used to perform diagnostic tests, reading central venous pressure, blood sampling, blood transfusion, and